Suppression of Core 1 Gal-Transferase Is Associated with Reduction of TF and Reciprocal Increase of Tn, sialyl-Tn and Core 3 Glycans in Human Colon Cancer Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Barrow, Hannah ^a   Tam, Benjamin ^a   Duckworth, Carrie A ^a   Rhodes, Jonathan M ^a   Yu, Lu Gang ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE BETA1,3 N ACETYLGALACTOSAMINE ALPHA; GALACTOSAMINE TRANSFERASE; LECTIN; LECTIN II; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE BETA1,3 N ACETYLGALACTOSAMINE ALPHA; SERINE; SIALYL N ACETYLGALACTOSAMINE ALPHA; SMALL INTERFERING RNA; THREONINE; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOSYNTHESIS; CANCER CELL CULTURE; CARBOHYDRATE ANALYSIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME BINDING; ENZYME MODIFICATION; ENZYME REPRESSION; GRIFFONIA; GRIFFONIA SIMPLICIFOLIA; HUMAN; HUMAN CELL; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RESIDUE ANALYSIS;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL LINE, TUMOR; COLONIC NEOPLASMS; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MUCINS; POLYSACCHARIDES; RNA INTERFERENCE;

EID: 84875412068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059792     Document Type: Article

References (43)

1. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, et al. (2012) Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22: 736-756.
2. Schjoldager KT, Clausen H, (2012) Site-specific protein O-glycosylation modulates proprotein processing- deciphering specific functions of the large polypeptide GalNAc-transferase gene family. Biochimica et biophysica acta 1820: 2079-2094.
3. Pratt MR, Hang HC, Ten Hagen KG, Rarick J, Gerken TA, et al. (2004) Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling. Chem Biol 11: 1009-1016.
4. Takeuchi H, Kato K, Hassan H, Clausen H, Irimura T, (2002) O-GalNAc incorporation into a cluster acceptor site of three consecutive threonines. Distinct specificity of GalNAc-transferase isoforms. European journal of biochemistry/FEBS 269: 6173-6183.
5. Wandall HH, Hassan H, Mirgorodskaya E, Kristensen AK, Roepstorff P, et al. (1997) Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1,-T2, and-T3. The Journal of biological chemistry 272: 23503-23514.
6. de Graffenried CL, Bertozzi CR, (2004) The roles of enzyme localisation and complex formation in glycan assembly within the Golgi apparatus. Curr Opin Cell Biol 16: 356-363.
7. Young WW Jr, (2004) Organization of Golgi glycosyltransferases in membranes: complexity via complexes. J Membr Biol 198: 1-13.
8. Bieberich E, Tencomnao T, Kapitonov D, Yu RK, (2000) Effect of N-glycosylation on turnover and subcellular distribution of N-acetylgalactosaminyltransferase I and sialyltransferase II in neuroblastoma cells. J Neurochem 74: 2359-2364.
9. Rottger S, White J, Wandall HH, Olivo JC, Stark A, et al. (1998) Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J Cell Sci 111 (Pt 1): 45-60.
10. Storrie B, White J, Rottger S, Stelzer EH, Suganuma T, et al. (1998) Recycling of golgi-resident glycosyltransferases through the ER reveals a novel pathway and provides an explanation for nocodazole-induced Golgi scattering. J Cell Biol 143: 1505-1521.
11. Ju T, Brewer K, D'Souza A, Cummings RD, Canfield WM, (2002) Cloning and expression of human core 1 beta1,3-galactosyltransferase. The Journal of biological chemistry 277: 178-186.
12. Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, et al. (2011) ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. Front Biosci (Elite Ed) 3: 1443-1455.
13. Marcos NT, Pinho S, Grandela C, Cruz A, Samyn-Petit B, et al. (2004) Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer research 64: 7050-7057.
14. Hounsell EF, Davies MJ, Renouf DV, (1996) O-linked protein glycosylation structure and function. Glycoconj J 13: 19-26.
15. Hanisch FG, (2001) O-glycosylation of the mucin type. Biological chemistry 382: 143-149.
16. Brockhausen I, (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochimica et biophysica acta 1473: 67-95.
17. Brockhausen I SH, Stanley P. (2009) O-GalNAc Glycans. In: Varki A CR, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editor. Essentials of Glycobiology. 2nd edition ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
18. Ju T, Cummings RD, (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proceedings of the National Academy of Sciences of the United States of America 99: 16613-16618.
19. Ju T, Cummings RD, (2005) Protein glycosylation: chaperone mutation in Tn syndrome. Nature 437: 1252.
20. Huet G, Kim I, de Bolos C, Lo-Guidice JM, Moreau O, et al. (1995) Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. Journal of cell science 108 (Pt 3): 1275-1285.
21. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, et al. (2007) Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. The Journal of biological chemistry 282: 773-781.
22. Yu LG, Jansson B, Fernig DG, Milton JD, Smith JA, et al. (1997) Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose beta1-3 N-acetyl-galactosamine). International journal of cancer 73: 424-431.
23. Goldstein IJ, Hayes CE, (1978) The lectins: carbohydrate-binding proteins of plants and animals. Advances in carbohydrate chemistry and biochemistry 35: 127-340.
24. Kellokumpu S, Sormunen R, Kellokumpu I, (2002) Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH. FEBS letters 516: 217-224.
25. Rivinoja A, Kokkonen N, Kellokumpu I, Kellokumpu S, (2006) Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen. Journal of cellular physiology 208: 167-174.
26. Campbell BJ, Yu LG, Rhodes JM, (2001) Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconjugate journal 18: 851-858.
27. Yu LG, (2007) The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression. Glycoconjugate journal 24: 411-420.
28. Springer GF, (1997) Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. Journal of molecular medicine 75: 594-602.
29. Ikeda Y, Kuwano H, Baba K, Ikebe M, Matushima T, et al. (1993) Expression of Sialyl-Tn antigens in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus. Cancer research 53: 1706-1708.
30. Terasawa K, Furumoto H, Kamada M, Aono T, (1996) Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells. Cancer research 56: 2229-2232.
31. Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P, (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast cancer research 12: 204.
32. Nakagoe T, Nanashima A, Sawai T, Tuji T, Yamaguchi E, et al. (2000) Different expression of sialyl Tn antigen between polypoid and nonpolypoid growth types of advanced colorectal carcinoma. Oncology 59: 131-138.
33. Itzkowitz S, Kjeldsen T, Friera A, Hakomori S, Yang US, et al. (1991) Expression of Tn, sialosyl Tn, and T antigens in human pancreas. Gastroenterology 100: 1691-1700.
34. Fu J, Wei B, Wen T, Johansson ME, Liu X, et al. (2011) Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. The Journal of clinical investigation 121: 1657-1666.
35. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, et al. (2005) Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America 102: 4572-4577.
36. Pinho S, Marcos NT, Ferreira B, Carvalho AS, Oliveira MJ, et al. (2007) Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. Cancer letters 249: 157-170.
37. Julien S, Adriaenssens E, Ottenberg K, Furlan A, Courtand G, et al. (2006) ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology 16: 54-64.
38. Zhao Q, Guo X, Nash GB, Stone PC, Hilkens J, et al. (2009) Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer research 69: 6799-6806.
39. Barrow H, Guo X, Wandall HH, Pedersen JW, Fu B, et al. (2011) Serum galectin-2,-4, and-8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clinical cancer research 17: 7035-7046.
40. Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, et al. (2010) Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Molecular cancer 9: 154.
41. Barrow H, Rhodes JM, Yu L-G, (2011) The role of galectins in colorectal cancer progression. Int J Cancer 129: 1-8.
42. Desai PR, Ujjainwala LH, Carlstedt SC, Springer GF, (1995) Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection. Journal of immunological methods 188: 175-185.
43. Heimburg-Molinaro J, Almogren A, Morey S, Glinskii OV, Roy R, et al. (2009) Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen. Neoplasia 11: 780-792.